RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
Sep. 30, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Jul. 28, 2016 |
|---|---|---|---|---|
| Compensation and interest payable | $ 71,029 | $ 69,803 | ||
| BioCorRx Pharmaceuticals [Member] | ||||
| Ownership retained percent | 75.80% | |||
| Management fee | 24.20% | |||
| Director [Member] | ||||
| Compensation and interest payable | $ 991,060 | $ 1,349,465 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of assumed life insurance contract issued and outstanding to life insurance contract issued and outstanding after effect of reinsurance, as disclosed in supplementary reinsurance information. Includes, but is not limited to, dividend and adjustment to face value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|